Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors

Emiel Leegwater, Anne Strik, Erik B Wilms, Liesbeth B E Bosma, David M Burger, Thomas H Ottens, Cees van Nieuwkoop
2020 Clinical Infectious Diseases  
We report a case of a male with COVID-19 who developed acute hepatotoxicity related to remdesivir with probable interaction of P-glycoprotein (P-gp) inhibitors. Until further details upon this interaction become available, we recommend physicians to be cautious with the prescription of P-gp inhibitors in patients receiving remdesivir therapy.
doi:10.1093/cid/ciaa883 pmid:32594120 fatcat:gvetydsvhbehpdpsginfq3exya